跳至主要内容
临床试验/JPRN-UMIN000045632
JPRN-UMIN000045632已完成Unknown

A clinical study for evaluating of the suppressive effect of a supplement containing complex ingredients on the elevation of postprandial serum triglyceride. - A clinical study for evaluating of the suppressive effect of a supplement containing complex ingredients on the elevation of postprandial serum triglyceride.

Medical Corporation Shoureikan Sinsapporo seiryou Hospital0 个研究点目标入组 40 人开始时间: 2022年12月1日最近更新:
适应症

试验速览

阶段
Unknown
状态
已完成
发起方
入组人数
40

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 65years-old(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1. Subjects with hepatic, renal, cardiac or organ disorders or diabetes or other serious diseases. 2. Subjects with a surgical history of digestive system (except appendicectom). 3. Subjects currently under treatment with chronic diseases. 4. Subjects with food allergies to the food ingredients used in the test. 5. Subjects who are pregnant or intend to become pregnant during the study or are lactating. 6. Subjects who are lactose intolerant or are susceptible to gastrointestinal symptoms of high-fat foods. 7. Heavy drinkers (average amount of intake as pure alcohol is 60 g or more per day) and excessive smokers (smoke more than 20 cigarettes per day). 8. Subjects who always take drugs or supplements which claim the suppressive absorption of sugar or lipid or reduction of triglyceride, etc. 9. Subjects who participate in other clinical trial. 10. Subjects who may feel unwell or deteriorate due to repeated blood collection. 11. Subjects who have donated or plan to donate 200 ml or more of blood separately from this study from 1 month before the primary screening to the end of the study. 12. Subjects who do not take breakfast. 13. Subjects who work from 22:00 to 6:00 (shift worker, night- shift worker, etc.) 14. Subject who cannot consume foods whose origin is not clearly indicated due to religious or other reasons. 15. Subjects judged as unsuitable for this study by the investigator for other reasons.

研究者

发起方
Medical Corporation Shoureikan Sinsapporo seiryou Hospital

相似试验